reviewTop 1% cited
PI3K pathway alterations in cancer: variations on a theme
Oncogene · 2008 · Vol. 27(41) · pp. 5497–5510
T L Yuan✉Lewis C. Cantley(Harvard University)
PI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and MutationsChronic Lymphocytic Leukemia ResearchPTENPI3K/AKT/mTOR pathwayBiologyP110αPhosphoinositide 3-kinaseCancer researchCancerReceptor tyrosine kinaseKinaseProtein kinase B
MeSH terms
Phosphoinositide-3 Kinase InhibitorsAnimalsAntineoplastic Combined Chemotherapy ProtocolsEnzyme InhibitorsHumansModels, BiologicalMutationNeoplasmsNuclear ProteinsGenes, rasTranscription FactorsSignal TransductionGenes, erbB-2Phosphatidylinositol 3-KinasesPTEN Phosphohydrolase
Citations
1,829
FWCI
46.89
field-weighted impact
References
85
Percentile
100%
vs. same field & year
Citations per year
Cited by
Fundamentals of cancer metabolism
Science Advances · 2016 · 2,929 citations
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Clinical Cancer Research · 2011 · 893 citations
ErbB receptors and signaling pathways in cancer
Current Opinion in Cell Biology · 2009 · 975 citations
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
Cell stem cell · 2011 · 823 citations
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Nature reviews. Cancer · 2009 · 2,438 citations
mTOR: from growth signal integration to cancer, diabetes and ageing
Nature Reviews Molecular Cell Biology · 2010 · 3,931 citations
The PTEN–PI3K pathway: of feedbacks and cross-talks
Oncogene · 2008 · 891 citations
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Frontiers in Oncology · 2018 · 401 citations
References
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Nature Reviews Genetics · 2006 · 3,288 citations
Putting tumours in context
Nature reviews. Cancer · 2001 · 2,159 citations
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
Cancer Cell · 2007 · 1,609 citations
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
Oncogene · 2007 · 1,204 citations
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Cancer Cell · 2004 · 1,856 citations
Targeting RAS signalling pathways in cancer therapy
Nature reviews. Cancer · 2003 · 3,219 citations
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
Cancer Research · 2004 · 4,006 citations
Angiogenesis: an organizing principle for drug discovery?
Nature Reviews Drug Discovery · 2007 · 2,228 citations
Related articles
PI3K pathway alterations in cancer: variations on a theme
Oncogene · 2008 · 1,829 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.